FDA Week - 03/15/2019

Azar Taps Nat’l Cancer Institute Director As Acting FDA Commissioner

March 12, 2019
National Cancer Institute Director Ned Sharpless will become acting commissioner of FDA when current Commissioner Scott Gottlieb resigns in early April, HHS Secretary Alex Azar announced at a House hearing Tuesday (March 12). Sharpless was among three candidates viewed as top contenders for the job, and Azar said Sharpless’ “deep scientific background and expertise will make him a strong leader for FDA,” he said. “There will be no let-up in the agency’s focus, from ongoing efforts on drug approvals and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.